Sharif M. Shaheen

483 total citations
26 papers, 407 citations indexed

About

Sharif M. Shaheen is a scholar working on Pharmaceutical Science, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Sharif M. Shaheen has authored 26 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 7 papers in Molecular Biology and 6 papers in Molecular Medicine. Recurrent topics in Sharif M. Shaheen's work include Advanced Drug Delivery Systems (7 papers), Advancements in Transdermal Drug Delivery (6 papers) and RNA Interference and Gene Delivery (6 papers). Sharif M. Shaheen is often cited by papers focused on Advanced Drug Delivery Systems (7 papers), Advancements in Transdermal Drug Delivery (6 papers) and RNA Interference and Gene Delivery (6 papers). Sharif M. Shaheen collaborates with scholars based in Japan, Bangladesh and Bulgaria. Sharif M. Shaheen's co-authors include Kazuo Yamaura, Hideyoshi Harashima, Hidetaka Akita, Takashi Nakamura, Lixing Dai, Maruf Ahmed, Naoya Miura, Atsushi Yamashita, Ryo Katoono and Nobuhiko Yui and has published in prestigious journals such as Nucleic Acids Research, Biomaterials and Cancer Research.

In The Last Decade

Sharif M. Shaheen

26 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharif M. Shaheen Japan 10 166 82 77 65 56 26 407
Sorina Nicoleta Voicu Romania 12 107 0.6× 95 1.2× 77 1.0× 39 0.6× 18 0.3× 31 510
Irfan Ahmad India 8 90 0.5× 98 1.2× 40 0.5× 58 0.9× 29 0.5× 12 353
Anca Maria Arseniu Romania 12 218 1.3× 119 1.5× 99 1.3× 42 0.6× 17 0.3× 22 699
Chiung‐Hung Chang Taiwan 12 138 0.8× 124 1.5× 57 0.7× 66 1.0× 11 0.2× 16 617
Tarun Kumar India 9 116 0.7× 117 1.4× 77 1.0× 26 0.4× 24 0.4× 26 478
Kiran Avadhani India 9 135 0.8× 65 0.8× 57 0.7× 35 0.5× 12 0.2× 11 572
Were L. L. Munyendo Kenya 8 198 1.2× 89 1.1× 43 0.6× 27 0.4× 10 0.2× 14 466
Supandeep Singh Hallan Italy 14 203 1.2× 126 1.5× 63 0.8× 52 0.8× 13 0.2× 20 690
Navneet Kumar Verma India 13 103 0.6× 102 1.2× 120 1.6× 55 0.8× 22 0.4× 93 588

Countries citing papers authored by Sharif M. Shaheen

Since Specialization
Citations

This map shows the geographic impact of Sharif M. Shaheen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharif M. Shaheen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharif M. Shaheen more than expected).

Fields of papers citing papers by Sharif M. Shaheen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharif M. Shaheen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharif M. Shaheen. The network helps show where Sharif M. Shaheen may publish in the future.

Co-authorship network of co-authors of Sharif M. Shaheen

This figure shows the co-authorship network connecting the top 25 collaborators of Sharif M. Shaheen. A scholar is included among the top collaborators of Sharif M. Shaheen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharif M. Shaheen. Sharif M. Shaheen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adu‐Amankwaah, Joseph, et al.. (2025). Estrogen via GPER downregulated HIF-1a and MIF expression, attenuated cardiac arrhythmias, and myocardial inflammation during hypobaric hypoxia. Molecular Medicine. 31(1). 107–107. 1 indexed citations
3.
Shaheen, Sharif M.. (2016). Advances in DNA vaccines for Cancer and many other Diseases. 2(4). 172–183. 2 indexed citations
4.
Shaheen, Sharif M.. (2016). Proteosomes and Immunoproteosomes in Vaccine Platform. 2(6). 234–236. 2 indexed citations
5.
Shaheen, Sharif M. & Md Kamrul Hasan. (2015). Kanamycin Potential of Papaya Fruit Stem Exudate in E. Coli. 1(1). 13–15. 2 indexed citations
6.
Miura, Naoya, Sharif M. Shaheen, Hidetaka Akita, Takashi Nakamura, & Hideyoshi Harashima. (2015). A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant. Nucleic Acids Research. 43(3). 1317–1331. 51 indexed citations
7.
Shaheen, Sharif M., et al.. (2015). Abstract 4535: Graphene/Pectin-NaCl based gel-biosensor for tracing skin cancer and delivery of anticancer drug paclitaxel. Cancer Research. 75(15_Supplement). 4535–4535. 1 indexed citations
8.
Shaheen, Sharif M. & Md. Nazir Hossen. (2015). Non-Fickian Transport of Pioglitazone from a CMC/PVA/SDS Blend Patch Gel. 1(1). 1–6. 1 indexed citations
9.
Shaheen, Sharif M., et al.. (2015). A therapeutic TDS patch of Metformin from a HPMC-PVA blend studied with a biological membrane of fish-swim bladder: An approach for dermal application in NIDDM.. PubMed. 28(5). 1619–24. 3 indexed citations
10.
Akita, Hidetaka, Naoya Miura, Sharif M. Shaheen, et al.. (2013). A DNA microarray-based analysis of immune-stimulatory and transcriptional responses of dendritic cells to KALA-modified nanoparticles. Biomaterials. 34(35). 8979–8990. 13 indexed citations
11.
Shaheen, Sharif M., Hidetaka Akita, Atsushi Yamashita, et al.. (2011). Quantitative analysis of condensation/decondensation status of pDNA in the nuclear sub-domains by QD-FRET. Nucleic Acids Research. 39(7). e48–e48. 26 indexed citations
12.
Shaheen, Sharif M., Hidetaka Akita, Takashi Nakamura, et al.. (2011). KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine. Biomaterials. 32(26). 6342–6350. 51 indexed citations
13.
Shaheen, Sharif M., et al.. (2011). <i>In vitro</i> Transdermal Delivery of Metformin from a HPMC/ PVA Based TDS-patch at Different pH. Journal of Scientific Research. 3(3). 651–657. 4 indexed citations
14.
Islam, Md. Amirul, Md. Sazzad Hossain, Mir Imam Ibne Wahed, et al.. (2009). Antidiabetic and Hypolipidemic Effects of Different Fractions of Catharanthus Roseus (Linn.) on Normal and Streptozotocin-induced Diabetic Rats. Journal of Scientific Research. 1(2). 334–344. 38 indexed citations
15.
Shaheen, Sharif M., et al.. (2006). Liposome as a Carrier for Advanced Drug Delivery. Pakistan Journal of Biological Sciences. 9(6). 1181–1191. 46 indexed citations
16.
Shaheen, Sharif M., et al.. (2004). Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.. PubMed. 14(4). 371–82. 1 indexed citations
17.
Shaheen, Sharif M. & Kazuo Yamaura. (2002). Preparation of theophylline hydrogels of atactic poly(vinyl alcohol)/NaCl/H2O system for drug delivery system. Journal of Controlled Release. 81(3). 367–377. 50 indexed citations
18.
Shaheen, Sharif M., et al.. (2002). Properties of hydrogels of atactic poly(vinyl alcohol)/NaCl/H2O system and their application to drug release. Polymer International. 51(12). 1390–1397. 29 indexed citations
19.
Jalil, R., et al.. (2000). Preparation and Stability Study of Diclofenac Sodium Suppositories. Pakistan Journal of Biological Sciences. 3(10). 1755–1757. 3 indexed citations
20.
Molla, Md. Khademul Islam, et al.. (1970). Rate Controlled Release of Naproxen from HPMC Based Sustained Release Dosage Form: I. Microcapsule Compressed Tablet and Matrices. Dhaka University Journal of Pharmaceutical Sciences. 4(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026